RecruitingNot ApplicableNCT05483283

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care


Sponsor

University of Illinois at Chicago

Enrollment

600 participants

Start Date

Jan 18, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The investigator and study staff will identify, recruit and randomize Latina participants with elevated genetic and Social Determinants of Heath (SDH) risks. Within 1 week of enrollment, all Latina Aim 1 participants in both study arms will engage in three 30-minute, individual, phone-based sessions with the study team across 3 consecutive weeks


Eligibility

Sex: FEMALEMin Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This program is designed to help Latina women at higher-than-average risk for breast cancer access genetic counseling, genetic testing, and cancer screenings. It aims to remove barriers — such as financial concerns, language, and transportation — that often prevent Latina women from getting the care they need. **You may be eligible if...** - You identify as Latina and are female - You are 30 or older - You have a personal history of breast cancer or a family history of breast or ovarian cancer - You have at least one social challenge such as financial difficulties, transportation problems, housing instability, or social isolation - You have not previously received genetic counseling or genetic testing for cancer risk **You may NOT be eligible if...** - You do not meet the age, identity, and risk factor requirements - You have already received cancer genetic counseling or testing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREmpowerment and Navigation

Empowerment and Navigation

OTHERSOC

SOC


Locations(1)

University of Illinois

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05483283


Related Trials